Siemens finds very high field MR partner
MR manufacturers agree that clinical sites considering the purchase of a high-performance scanner are now seriously examining 3T systems alongside 1.5T scanners--and choosing 3T, if their budgets permit. With that realization, Siemens Medical Solutions
MR manufacturers agree that clinical sites considering the purchase of a high-performance scanner are now seriously examining 3T systems alongside 1.5T scanners--and choosing 3T, if their budgets permit. With that realization, Siemens Medical Solutions has cut an agreement to collaborate with the Biomedical Imaging Technology Center (BITC) at Emory University to develop new clinical MR applications. Using its new Magnetom Trio 3T scanner, Siemens and BITC are preparing to launch projects aimed at advancing the physics and chemistry of 3T MR, as well as enhancing the hardware and software of 3T technology. The whole-body scanner will be focused on certain advanced clinical applications, including cardiovascular pathologies, musculoskeletal diseases, venous tumors, and anatomic and functional aspects of the brain.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
